Chemical Dependency Overview
Another name for Chemical Dependency is Addiction.
What is an addiction?
A person with an addiction has an emotional, psychological, or physical dependency on a given behavior. Drug and alcohol addiction are the two most common addictions that physicians treat. Both of these addictions interfere with the person's relationships, family life, and occupation. Over time, the toxic effects of a chemical, such as a drug or alcohol, can damage the brain, heart, liver, and nerves. Alcohol can cause scarring and irreversible damage to the liver, called alcoholic cirrhosis. Narcotic addiction can lead to irreversible kidney damage and kidney failure.
What are the symptoms of an addiction?
The symptoms of an addiction depend on the type of chemical dependency. Symptoms of alcohol addiction include alcohol craving, anxiety, inability to stop drinking, blackouts, loss of memory, anger, violence, insomnia, and paranoid behavior. Symptoms of drug addiction are similar to alcohol addiction, but may also vary with the type of drug that is being abused. Sedative drugs cause symptoms that are very different than stimulant drugs. Symptoms can be broken down into: symptoms of GHB, symptoms of hallucinogens, symptoms of narcotics, symptoms or sedatives, and symptoms of stimulants.
How does a doctor treat an addiction?
Treatment for an addiction depends on the underlying chemical dependency. Treatment for alcohol addiction requires the strict avoidance of alcohol, medications that suppress alcohol craving, alcoholism support groups, and psychological counseling. Treatment for drug addiction may include mental health counseling, support groups, social services, drug detoxification, and medications to control the symptoms of drug withdrawal.
Continue to Chemical Dependency Symptoms
- American Medical Association: Alcoholism in the elderly. Council on Scientific Affairs, American Medical Association. JAMA 1996 Mar 13; 275(10): 797-801. 
- Galea S, Nandi A, Vlahov D. The social epidemiology of substance use. Epidemiol Rev. 2004;26:36-52. 
- Isaacson JH, Hopper JA, Alford DP, Parran T. Prescription drug use and abuse. Risk factors, red flags, and prevention strategies. Postgrad Med. 2005 Jul;118(1):19-26. 
- Karch SB. Cocaine cardiovascular toxicity. South Med J. 2005 Aug;98(8):794-9. 
- Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2004;(3):CD002207. 
- O'Connor PG, Schottenfeld RS: Patients with alcohol problems. N Engl J Med 1998 Feb 26; 338(9): 592-602. 
- Piccinelli M, Tessari E, et al: Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study. BMJ 1997 Feb 8; 314(7078): 420-4. 
- Room R, Babor T, Rehm J: Alcohol and public health. Lancet 2005 Feb 5; 365(9458): 519-30. 
- Saitz R: Clinical practice. Unhealthy alcohol use. N Engl J Med 2005 Feb 10; 352(6): 596-607. 
- Scott LJ, Figgitt DP, Keam SJ, Waugh J. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence. CNS Drugs. 2005;19(5):445-64. 
- Skiba D, Monroe J, Wodarski JS. Adolescent substance use: reviewing the effectiveness of prevention strategies. Soc Work. 2004 Jul;49(3):343-53. 
- Wilk AI, Jensen NM, Havighurst TC: Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers. J Gen Intern Med 1997 May; 12(5): 274-83. 
- Willner IR, Reuben A. Alcohol and the liver. Curr Opin Gastroenterol. 2005 May;21(3):323-30.